Jizhao Wang

Prof. Jizhao Wang

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2023 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
GSGao Shan
Gao Shan
KMKang Minchao
Kang Minchao
JWJizhao Wang
Jizhao Wang
ZRZhao Rui
Zhao Rui
ZGZhang Guangjian
Zhang Guangjian
LMLi Meihe
Li Meihe

17 November 2025 in EBioMedicine
Verified
Journal Article
Open access
GZGuangjian Zhang
Guangjian Zhang
BLBohao Liu
Bohao Liu
DQDeqian Qiao
Deqian Qiao
SGShan Gao
Shan Gao
XZXingzhuo Zhu
Xingzhuo Zhu
QGQiuyu Gong
Qiuyu Gong
Previous targeted therapies for non-small cell lung cancer (NSCLC) have focused on targeting driver mutations (e.g., EGFR/ALK), leading to approximately 30-40% of patients with negative mutations lacking effective treatments. Therefore, there is an urgent need for innovative therapeutic strategies for these patients. CD26-targeted proteolysis-targeting chimeras (PROTACs: P4-1 to P4-4) were designed and synthesised. The binding strengths between degraders and CD26 were evaluated through surface plasmon resonance (SPR). The ternary complex formations were confirmed by NanoBRET™ live-cell ternary complex profiling assay. Driver-negative NSCLC (NCI-H460 and NCI-H1299) and BEAS-2B cells were used to study the degradation performances of degraders. The therapeutic efficacies of the optimal degrader (P4-3) were assessed via cell line-derived xenografts (CDX), in situ lung cancer and patient-derived organoids (PDOs) models. Mechanistic studies incorporated co-immunoprecipitation, immunofluorescence, reactive oxygen species (ROS)/DNA damage detection, apoptosis assays and transcriptomics. CD26 underwent clathrin-dependent endocytosis induced by P4-3 and ternary complex were formed before protein degradation. Degradation of CD26 by P4-3 resulted in the cytoplasmic translocation of membrane-bound adenosine deaminase (ADA), leading to adenosine depletion, mitochondrial ROS accumulation, metabolic stress, DNA damage, and intrinsic apoptosis in vitro, in vivo and in PDOs (negative mutations) models. Mechanistically, degradation of CD26 uniquely eliminates both its enzymatic activity and non-enzymatic functions, achieving a dual effect unattainable with conventional inhibitors. Targeted CD26 degradation represents a valuable therapeutic strategy for driver-negative NSCLC. And this approach also addresses the limitations of driver mutation-targeted based therapies, providing a promising method for NSCLC patients with negative mutations. This study was funded by the Key Research and Development Project of Shaanxi Province (2023-YBSF-292), the opening foundation (M2022-3) from Key Laboratory of Optic-Electric Sensing and Analytical Chemistry for Life Science, Ministry of Education, Qingdao University of Science and Technology, the National Natural Science Foundation of China (82102976, 52203337), the Youth Top Talent Program (11301223010722) from Xi'an Jiaotong University, the Key Research and Development Project of Shaanxi Province (2024SF-ZDCYL-02-09) and Capacity Improvement Plan of Shaanxi Health Committee (2024PT-09).

12 January 2026 in Advanced Science
Verified
Journal Article
Open access
JHJiaqi Huang
Jiaqi Huang
BLBohao Liu
Bohao Liu
XZXingzhuo Zhu
Xingzhuo Zhu
DQDeqian Qiao
Deqian Qiao
SCSizhe Chen
Sizhe Chen
QGQiuyu Gong
Qiuyu Gong
Antimicrobial peptides (AMPs) are promising alternatives to overcome antimicrobial resistance (AMR). However, precise construction of an AMP targeting bacterial cell membranes derived from natural peptides remains a great challenges. Although the artificial intelligence (AI) algorithm‐assisted screening method has achieved unprecedented successes, it's difficult to predict the targets of AMPs obtained from this method. To address this, an AMP ( P 3‐3R‐8I ) based on several natural peptides derived from insect cuticle was constructed precisely via amino acid mutation. The mutated amino acids Arginine (R) and Isoleucine (I) are expected to target the bacterial cell membranes. Surprisingly, P 3‐3R‐8I exhibits super antibacterial capability against two representative bacteria: methicillin‐resistant Staphylococcus aureus (MRSA) and Escherichia coli ( E. coli ), which could be attributed to the ability to quickly penetrate bacterial cell membranes and then to bind to bacterial DNA of P 3‐3R‐8I , resulting in the suppression of DNA replication. In rats’ model, the MRSA‐infected wound could be alleviated by P 3‐3R‐8I obviously, as well as lung and spleen infections in MRSA‐induced systemic sepsis. Our findings provide a prospect for the precise construction of AMPs targeting bacterial cell membranes as well as a means of overcoming AMR, offering a strategy for drug‐resistant bacteria‐induced tissue repair.

27 January 2026 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
JWJizhao Wang
Jizhao Wang
KDKe Dong
Ke Dong
YLYixing Li
Yixing Li
CZChuqiao Zheng
Chuqiao Zheng
DQDeqian Qiao
Deqian Qiao
GZGuangjian Zhang
Guangjian Zhang